首页> 外文OA文献 >509. Dose Escalation of Therapeutic High-Capacity, Gutless Adenoviral Vectors in the Naïve Rat Brain: Pre-Clinical Safety and Toxicity Evaluation as a Prelude to a Phase I Clinical Trial for Glioma

【2h】

509. Dose Escalation of Therapeutic High-Capacity, Gutless Adenoviral Vectors in the Naïve Rat Brain: Pre-Clinical Safety and Toxicity Evaluation as a Prelude to a Phase I Clinical Trial for Glioma

机译：509.幼稚大鼠脑中的治疗高容量，无高腺病毒载体的剂量升级：临床安全性和毒性评估作为胶质瘤的I期临床试验的前奏性

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者

展开▼
作者单位

展开▼
年度 2011
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献

1. Study of the efficacy, biodistribution, and safety profile of therapeutic gutless adenovirus vectors as a prelude to a phase I clinical trial for glioblastoma. [J] . Muhammad AK, Puntel M, Candolfi M, Clinical Pharmacology and Therapeutics . 2010,第2期

机译：研究治疗性无肠腺病毒载体的功效，生物分布和安全性，以此作为胶质母细胞瘤I期临床试验的序幕。
2. Preclinical Efficacy and Safety Profile of Allometrically Scaled Doses of Doxycycline Used to Turn "On'' Therapeutic Transgene Expression from High-Capacity Adenoviral Vectors in a Glioma Model [J] . VanderVeen Nathan, Raja Nicholas, Yi Elizabeth, Human gene therapy methods. . 2016,第3期

机译：等速测比剂量多西环素的临床前疗效和安全性概况，用于在胶质瘤模型中从高容量腺病毒载体“打开”治疗性转基因表达
3. Effective high-capacity gutless adenoviral vectors mediate transgene expression in human glioma cells. [J] . Candolfi M, Curtin JF, Xiong WD, Molecular therapy: the journal of the American Society of Gene Therapy . 2006,第3期

机译：有效的高容量无肠腺病毒载体介导人神经胶质瘤细胞中的转基因表达。
4. Initial Formal Toxicity Evaluation of APC-2, a Novel Fluorescent Tracer Agent for Real-Time Measurement of Glomerular Filtration Rate in Preparation for a first-in-man clinical trial [C] . Joseph E. Bugaj, Richard B. Dorshow Reporters, markers, dyes, nanoparticles, and molecular probes for biomedical applications VI . 2014

机译：APC-2的初步形式毒性评估，一种新型荧光示踪剂，用于实时测量肾小球滤过率，准备进行首次人体试验
5. Study of the Efficacy Biodistribution and Safety Profile of Therapeutic Gutless Adenovirus Vectors as a Prelude to a Phase I Clinical Trial for Glioblastoma [O] . AKMG Muhammad, M Puntel, M Candolfi, -1

机译：研究治疗无肠腺病毒载体的功效生物分布和安全性作为前奏为胶质母细胞瘤I期临床试验
6. Safety Profile of Gutless Adenovirus Vectors Delivered into the Normal Brain Parenchyma: Implications for a Glioma Phase 1 Clinical Trial [O] . Ghulam Muhammad, A.K.M., Xiong, Weidong, Puntel, Mariana, 2012

机译：无肠腺病毒载体的安全性传递到正常脑实质：对胶质瘤1期临床试验的影响

509. Dose Escalation of Therapeutic High-Capacity, Gutless Adenoviral Vectors in the Naïve Rat Brain: Pre-Clinical Safety and Toxicity Evaluation as a Prelude to a Phase I Clinical Trial for Glioma

著录项

引文网络

相似文献

相关主题

期刊订阅